Cargando…

What do we still need to learn on digitally assessed biomarkers?

Detalles Bibliográficos
Autores principales:	Acs, Balazs, Salgado, Roberto, Hartman, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361281/ https://www.ncbi.nlm.nih.gov/pubmed/34388519 http://dx.doi.org/10.1016/j.ebiom.2021.103520

Ejemplares similares

Do we still need supertrees?
por: Haeseler, Arndt von
Publicado: (2012)

Commentary: What do we still have to learn from surgery?
por: Belluschi, Igor, et al.
Publicado: (2021)

What have we learned and what do we still need to learn about nPDF?
por: Paakkinen, Petja
Publicado: (2021)

Cryoballoon ablation: Do we still need real-time recordings?
por: Bisignani, Antonio, et al.
Publicado: (2021)

Commentary: Extracorporeal membrane oxygenation for patients with refractory Coronavirus Disease 2019 (COVID-19): What do we know and what do we need to learn?
por: Jacobs, Jeffrey P., et al.
Publicado: (2022)

Do we really need standards in digital image management?
por: Ho, ELM
Publicado: (2008)

First-Episode Psychosis care in Central Europe: What we have learned and what we still need to do
por: Réthelyi, J.
Publicado: (2022)

Why do we still permit tobacco use?
por: Tiffin, Norman H
Publicado: (2015)

Phytochemical Molluscicides and Schistosomiasis: What We Know and What We Still Need to Learn
por: Augusto, Ronaldo de Carvalho, et al.
Publicado: (2018)

Do we still need animals? Surveying the role of animal‐free models in Alzheimer’s and Parkinson’s disease research
por: Aerts, Liesbeth, et al.
Publicado: (2022)

Management of epilepsy in pregnancy: What we still need to learn
por: Tomson, Torbjörn, et al.
Publicado: (2023)

Why do we still need participatory technology assessment?
por: Hennen, Leonhard
Publicado: (2012)

Opinion: PARP inhibitors in cancer—what do we still need to know?
por: Wicks, Andrew J., et al.
Publicado: (2022)

Antimicrobial Mouthwashes: An Overview of Mechanisms—What Do We Still Need to Know?
por: Brookes, Zoë, et al.
Publicado: (2023)

Pregnant adolescents living with HIV: what we know, what we need to know, where we need to go
por: Callahan, Tegan, et al.
Publicado: (2017)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Understanding the lingering consequences of what we treat and what we do
por: Angus, Derek C
Publicado: (2004)

Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?
por: Slattery, Jim, et al.
Publicado: (2020)

Antithyroid drug induced agranulocytosis: what still we need to learn ?
por: Chaudhry, Liaqat Ali, et al.
Publicado: (2016)

Medical students find assessments stressful. Of course….but what do we do about it?
por: LeBlanc, Vicki R.
Publicado: (2014)

Do we need an assessment of the nutrition risk in the critically ill patient?
por: Preiser, Jean-Charles
Publicado: (2012)

Assessing outcomes of health and medical research: do we measure what counts or count what we can measure?
por: Wells, Robert, et al.
Publicado: (2007)

The FIRE AND ICE Trial: What We Know, What We Can Still Learn, and What We Need to Address in the Future
por: Kuck, Karl‐Heinz, et al.
Publicado: (2018)

In a search of a protective titer: Do we or do we not need to know?
por: Baranova, Ancha, et al.
Publicado: (2021)

Ten myths and twenty years: What we know and what we still do not know about work addiction: Commentary on: Ten myths about work addiction (Griffiths et al., 2018)
por: Kun, Bernadette
Publicado: (2018)

Why we still need drugs for COVID‐19 and can't just rely on vaccines
por: Robinson, Bruce W. S., et al.
Publicado: (2021)

Vita activa in biotechnology: what we do with fungi and what fungi do with us
por: Weinhold, Martin, et al.
Publicado: (2017)

What we need is person-centred care
por: Stuart, Heather
Publicado: (2017)

Erratum: antithyroid drug induced agranulocytosis: what still we need to learn?
Publicado: (2016)

What can we do about osteoarthritis?
por: Lohmander, L Stefan
Publicado: (2000)

The WSES: what do we see in the future?
por: De Simone, Belinda, et al.
Publicado: (2021)

Can we do for other essential medicines what we are doing for the COVID-19 vaccine?
por: Murphy, Adrianna, et al.
Publicado: (2021)

Tight glycemic control: what do we really know, and what should we expect?
por: Nasraway, Stanley A, et al.
Publicado: (2010)

Ocular surface inflammation in dry eye disease: What we know and what we do not
por: Vazirani, Jayesh
Publicado: (2018)

What Do We Demand? Responding to the Call for Precision and Definitional Agreement in Family Planning’s “Demand” and “Need” Jargon
por: Fabic, Madeleine Short
Publicado: (2022)

Early goal-directed therapy: what do we do now?
por: Levy, Mitchell M
Publicado: (2014)

Why do we need improved mobility technology?
por: Boninger, Michael L, et al.
Publicado: (2012)

Why Do We Need To Diversify the Microbial Sciences?
por: Torres, Alfredo G.
Publicado: (2021)

Advance care planning; we need to do it more, but it needs to be done differently
por: Heyland, Daren K.
Publicado: (2020)

Endotracheal tube leak: What should we do?
por: Gupta, Nishkarsh
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c11b3oh8nloo2vtgmq5onjhk5k